20 May 2026
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
Facilitators:
O. De Backer, L. Rosseel
Discussants:
X. Freixa, T. Pilgrim
Summary
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the CHAMPION and PRO-TAVI studies to inform clinical decision-making.
Learning Objectives
- To reflect about the impact of recent trials on daily practice
- To discuss about the optimal management of coronary artery disease in TAVI candidates
- To review the current indication of LAA closure